Shingrix was approved by the US Food and Drug Administration (FDA) for the prevention shingles in adults 50 years of age or older in 2017. In 2018, the European Commission gave Shingrix approval for the prevention of shingles in adults 50 years of age or older. Global estimates suggest that 1 out of 3 people develops shingles in their lifetime.
Shingrix is the world
